Cost-effective BRCA Testing in Advanced Ovarian Cancer

Ann Lab Med. 2023 Jan 1;43(1):3-4. doi: 10.3343/alm.2023.43.1.3. Epub 2022 Sep 1.
No abstract available

Keywords: BRCA1; BRCA2; Genetic testing; Ovarian cancer.

Publication types

  • Editorial

MeSH terms

  • BRCA1 Protein / genetics
  • BRCA2 Protein / genetics
  • Breast Neoplasms*
  • Cost-Benefit Analysis
  • Female
  • Genetic Predisposition to Disease
  • Genetic Testing
  • Germ-Line Mutation
  • Humans
  • Mutation
  • Ovarian Neoplasms* / diagnosis
  • Ovarian Neoplasms* / genetics

Substances

  • BRCA1 Protein
  • BRCA2 Protein